Prerna Jadhav specialises in medical biotechnology research with a focus on molecular biology, cancer immunology, and the development of next-generation immunotherapies.
Prerna Jadhav is a Master of Biotechnology student at The University of Queensland whose research examines mRNA-based cytokine approaches to modulating immune responses in cancer. Her work involves characterising cytokine expression on transfected cells and assessing their potential to support T cell activation and expansion. She has a strong background in molecular biology, microbiology, and immunology, with prior research experience spanning biodegradation and bioethanol production. Her long-term research interests lie in advancing translational biotechnology and developing innovative therapeutic strategies in oncoimmunology.